☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Actemra
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
March 29, 2023
Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's EUA for Hospitalized Patients with COVID-19
June 25, 2021
Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia
September 18, 2020
Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions
June 26, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.